CTT Pharmaceutical Holdings, Inc. (CTTH)

Market Cap	3.27M
Revenue (ttm)	n/a
Net Income (ttm)	-1.67M
Shares Out	57.28M
EPS (ttm)	-0.08
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	39,463
Average Volume	52,363
Open	0.0490
Previous Close	0.0620
Day's Range	0.0490 - 0.0571
52-Week Range	0.0150 - 0.1518
Beta	0.91
RSI	50.66
Earnings Date	n/a

About CTTH

CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company’s technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered wafer, an orally administrable wafer comprising at least one physiologically acceptable film for...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Ryan Khouri
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: CTTH